SCHEMBL4289134

SCHEMBL4289134

CCOC(=O)c1nc(CC)[nH]c1N

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 2/20 0.47
HPGD P15428 2/20 0.47
CYP1A2 P05177 1/20 0.47
HTT P42858 1/20 0.47
RECQL P46063 1/20 0.47
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
MAPT P10636 3/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4566224 0.83 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDCYP1A2HTT
SCHEMBL8292169 0.83 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDCYP1A2HTT
SCHEMBL2523099 0.81 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDCYP1A2HTT
SCHEMBL7309272 0.81 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDCYP1A2HTT
SCHEMBL9115868 0.81 RNASEH1 (0.53) ALDH1A1KDM4EHPGDCYP1A2HTT
SCHEMBL27233076 0.80 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDCYP1A2HTT
SCHEMBL12465067 0.79 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDCYP1A2HTT
SCHEMBL13447864 0.78 RNASEH1 (0.52) ALDH1A1KDM4EHPGDCYP1A2MAPT
SCHEMBL19116493 0.76 HDAC4 (0.40) ALDH1A1KDM4EHPGDCYP1A2HTT
SCHEMBL9310219 0.75 ALDH1A1 (0.53) ALDH1A1KDM4EHPGDCYP1A2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061470-A2 HALOALKYL-SUBSTITUTED PYRIMIDINONE DERIVATIVES Neurogen Corporation (US) 2009-05-27 EP disclosed
WO-2008024433-A2 HALOALKYL-SUBSTITUTED PYRIMIDINONE DERIVATIVES NEUROGEN CORPORATION (US) 2008-02-28 WO disclosed